Paul Lubock

Paul is a Principal and a founder of Inceptus Medical, a medical device incubator founded in 2011. At Inceptus he was a founder of Inari Medical (NASDAQ: NARI) and served as Vice President until 2017 and on the Board of Directors from 2011 until 2020. At Inceptus, he is also a founder of Okami Medical and serves as Vice President and on the Board of Directors. He also served as Okami’s Vice President of R&D and Operations. Prior to Inceptus, he was a founder of SenoRx, which was acquired by C.R. Bard for $213M. He served as Chief Technical Officer from 1999 and Senior Vice President from April 2009 until his departure in 2011. Paul also served on the Board of Directors from 1998 to 2001 and served as Chief Operating Officer from 1998 to 1999. Prior to 1998, Paul was a founder and President of Abacus Design & Development, a medical product development company, and the founder of Laparomed, which was acquired by Advanced Surgical. Paul held various positions at Laparomed, including President, Vice President of Engineering and served on its Board of Directors. Previously he was Vice President of Engineering at Medstone and held engineering management roles at Shiley/Pfizer and Thoratec. Paul holds over 185 issued U.S. patents. He earned his B.A. in Applied Mechanics and Engineering Science from the University of California, San Diego and his M.S. in Mechanical Engineering from the University of California, Berkeley.